COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns - PubMed (original) (raw)
. 2022 Aug;10(8):e1099-e1114.
doi: 10.1016/S2214-109X(22)00233-9. Epub 2022 Jun 1.
Humphrey Cyprian Karamagi 2, Hillary Kipchumba Kipruto 3, Joseph Kyalo Mungatu 4, James Avoka Asamani 3, Benson Droti 3, Regina Titi-Ofei 5, Aminata Binetou Wahebine Seydi 5, Solyana Ngusbrhan Kidane 5, Thierno Balde 6, Abdou Salam Gueye 6, Lindiwe Makubalo 1, Matshidiso R Moeti 1
Affiliations
- PMID: 35659911
- PMCID: PMC9159735
- DOI: 10.1016/S2214-109X(22)00233-9
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns
Joseph Waogodo Cabore et al. Lancet Glob Health. 2022 Aug.
Abstract
Background: COVID-19 has affected the African region in many ways. We aimed to generate robust information on the transmission dynamics of COVID-19 in this region since the beginning of the pandemic and throughout 2022.
Methods: For each of the 47 countries of the WHO African region, we consolidated COVID-19 data from reported infections and deaths (from WHO statistics); published literature on socioecological, biophysical, and public health interventions; and immunity status and variants of concern, to build a dynamic and comprehensive picture of COVID-19 burden. The model is consolidated through a partially observed Markov decision process, with a Fourier series to produce observed patterns over time based on the SEIRD (denoting susceptible, exposed, infected, recovered, and dead) modelling framework. The model was set up to run weekly, by country, from the date the first infection was reported in each country until Dec 31, 2021. New variants were introduced into the model based on sequenced data reported by countries. The models were then extrapolated until the end of 2022 and included three scenarios based on possible new variants with varying transmissibility, severity, or immunogenicity.
Findings: Between Jan 1, 2020, and Dec 31, 2021, our model estimates the number of SARS-CoV-2 infections in the African region to be 505·6 million (95% CI 476·0-536·2), inferring that only 1·4% (one in 71) of SARS-CoV-2 infections in the region were reported. Deaths are estimated at 439 500 (95% CI 344 374-574 785), with 35·3% (one in three) of these reported as COVID-19-related deaths. Although the number of infections were similar between 2020 and 2021, 81% of the deaths were in 2021. 52·3% (95% CI 43·5-95·2) of the region's population is estimated to have some SARS-CoV-2 immunity, given vaccination coverage of 14·7% as of Dec 31, 2021. By the end of 2022, we estimate that infections will remain high, at around 166·2 million (95% CI 157·5-174·9) infections, but deaths will substantially reduce to 22 563 (14 970-38 831).
Interpretation: The African region is estimated to have had a similar number of COVID-19 infections to that of the rest of the world, but with fewer deaths. Our model suggests that the current approach to SARS-CoV-2 testing is missing most infections. These results are consistent with findings from representative seroprevalence studies. There is, therefore, a need for surveillance of hospitalisations, comorbidities, and the emergence of new variants of concern, and scale-up of representative seroprevalence studies, as core response strategies.
Funding: None.
© 2022 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY NC ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Figures
Figure 1
Adapted POMP model for SARS-CoV-2 transitions and outcomes POMP=partially observed Markov decision process.
Figure 2
Trends in SARS-CoV-2 infections and COVID-19-related deaths, Jan 1, 2020–Dec 31, 2021 COVID-19 mortality trends for different country-income levels (A) and regional economic communities (B) in the WHO African region.
Comment in
- Underestimated COVID-19 mortality in WHO African region.
Bradshaw D, Dorrington R, Moultrie T, Groenewald P, Moultrie H. Bradshaw D, et al. Lancet Glob Health. 2022 Nov;10(11):e1559. doi: 10.1016/S2214-109X(22)00425-9. Lancet Glob Health. 2022. PMID: 36240818 Free PMC article. No abstract available. - Underestimated COVID-19 mortality in WHO African region - Authors' reply.
Cabore JW, Karamagi H, Kipruto HK, Mungatu JK, Asamani JA, Droti B, Titi-Ofei R, Seydi ABW, Kidane SN, Balde T, Gueye AS, Makubalo L, Moeti MR. Cabore JW, et al. Lancet Glob Health. 2022 Nov;10(11):e1560. doi: 10.1016/S2214-109X(22)00415-6. Lancet Glob Health. 2022. PMID: 36240819 Free PMC article. No abstract available.
Similar articles
- Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
COVID-19 Cumulative Infection Collaborators. COVID-19 Cumulative Infection Collaborators. Lancet. 2022 Jun 25;399(10344):2351-2380. doi: 10.1016/S0140-6736(22)00484-6. Epub 2022 Apr 8. Lancet. 2022. PMID: 35405084 Free PMC article. - Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
COVID-19 Excess Mortality Collaborators. COVID-19 Excess Mortality Collaborators. Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10. Lancet. 2022. PMID: 35279232 Free PMC article. - COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
Barchuk A, Skougarevskiy D, Kouprianov A, Shirokov D, Dudkina O, Tursun-Zade R, Sergeeva M, Tychkova V, Komissarov A, Zheltukhina A, Lioznov D, Isaev A, Pomerantseva E, Zhikrivetskaya S, Sofronova Y, Blagodatskikh K, Titaev K, Barabanova L, Danilenko D. Barchuk A, et al. PLoS One. 2022 Jun 15;17(6):e0266945. doi: 10.1371/journal.pone.0266945. eCollection 2022. PLoS One. 2022. PMID: 35704649 Free PMC article. - Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
Haas EJ, McLaughlin JM, Khan F, Angulo FJ, Anis E, Lipsitch M, Singer SR, Mircus G, Brooks N, Smaja M, Pan K, Southern J, Swerdlow DL, Jodar L, Levy Y, Alroy-Preis S. Haas EJ, et al. Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22. Lancet Infect Dis. 2022. PMID: 34562375 Free PMC article. - COVID-19 in the Arab countries: Three-year study.
Alwahaibi N, Al Maskari M, Al-Jaaidi S, Al Dhahli B, Al Issaei H, Al Bahlani S. Alwahaibi N, et al. F1000Res. 2024 May 29;12:1448. doi: 10.12688/f1000research.142541.3. eCollection 2023. F1000Res. 2024. PMID: 38854702 Free PMC article. Review.
Cited by
- Underestimated COVID-19 mortality in WHO African region - Authors' reply.
Cabore JW, Karamagi H, Kipruto HK, Mungatu JK, Asamani JA, Droti B, Titi-Ofei R, Seydi ABW, Kidane SN, Balde T, Gueye AS, Makubalo L, Moeti MR. Cabore JW, et al. Lancet Glob Health. 2022 Nov;10(11):e1560. doi: 10.1016/S2214-109X(22)00415-6. Lancet Glob Health. 2022. PMID: 36240819 Free PMC article. No abstract available. - SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali.
Laverdure S, Kazadi D, Kone K, Callier V, Dabitao D, Dennis D, Haidara MC, Hunsberger S, Mbaya OT, Ridzon R, Sereti I, Shaw-Saliba K; InVITE Study Team. Laverdure S, et al. Int J Infect Dis. 2024 May;142:106985. doi: 10.1016/j.ijid.2024.106985. Epub 2024 Feb 28. Int J Infect Dis. 2024. PMID: 38417612 - Spatial and spatio-temporal epidemiological approaches to inform COVID-19 surveillance and control: a systematic review of statistical and modelling methods in Africa.
Odhiambo JN, Dolan CB, Troup L, Rojas NP. Odhiambo JN, et al. BMJ Open. 2023 Jan 25;13(1):e067134. doi: 10.1136/bmjopen-2022-067134. BMJ Open. 2023. PMID: 36697047 Free PMC article. - Population-based assessment of the burden of COVID-19 infection in African countries: a first-year report card and public health implications.
Mgbere O, Nwabuko OC, Olateju OA, Adepoju OE, Liaw W, Darkoh C, Essien EJ. Mgbere O, et al. Ther Adv Infect Dis. 2023 Sep 28;10:20499361231202116. doi: 10.1177/20499361231202116. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37779674 Free PMC article. - Assessment of lung injury severity using ultrasound in critically ill COVID-19 patients in resource limited settings.
Beye SA, Diallo B, Keita M, Cissoko Y, Ouattara K, Dicko H, Shabani M, Sidibé A, Berthé M, Coulibaly YI, Diani N, Keita M, Toloba Y, Dao S, Suttels V, Coulibaly Y, Mekontso Dessap A. Beye SA, et al. Ann Intensive Care. 2023 Apr 27;13(1):33. doi: 10.1186/s13613-023-01133-w. Ann Intensive Care. 2023. PMID: 37103717 Free PMC article.
References
- WHO WHO coronavirus (COVID-19) dashboard. https://covid19.who.int
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous